$1.29 Billion is the total value of Reynders McVeigh Capital Management, LLC's 208 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Definitive Healthcare Corp Cla | $388,000 | – | 25,000 | +100.0% | 0.03% | – | |
| DOV | New | Dover Corp | $295,000 | – | 2,534 | +100.0% | 0.02% | – |
| VO | New | Vanguard Mid Cap ETFmid cap etf | $245,000 | – | 1,303 | +100.0% | 0.02% | – |
| CRSP | New | Crispr Therapeuticsnamen akt | $202,000 | – | 3,085 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MasterCard Incorporated | 45 | Q2 2024 | 4.8% |
| ROCKWELL AUTOMATION INC | 45 | Q2 2024 | 4.2% |
| The Procter & Gamble Company | 45 | Q2 2024 | 5.9% |
| CVS Health Corporation | 45 | Q2 2024 | 5.7% |
| CANADIAN NATL RY CO | 45 | Q2 2024 | 3.5% |
| Danaher Corporation | 45 | Q2 2024 | 4.6% |
| JOHNSON & JOHNSON | 45 | Q2 2024 | 4.0% |
| Novartis AG Sp ADR | 45 | Q2 2024 | 4.0% |
| ILLUMINA INC | 45 | Q2 2024 | 3.3% |
| Microsoft Corporation | 45 | Q2 2024 | 4.7% |
View Reynders McVeigh Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-14 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-05 |
View Reynders McVeigh Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.